Cargando…

SERUM BIOMARKERS IN MORTALITY RISK STRATIFICATION IN PATIENTS, HOSPITALIZED WITH COVID-19 PNEUMONIA IN EARLY AND REMOTE PERIOD

Detalles Bibliográficos
Autores principales:	Zagidullin, Naufal, Ruslan, Gumerov, Anton, Tyurin, Paruir, Davtayn, Sergey, Dozhdev, Irina, Lakman, Valentin, Pavlov
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Cardiology Foundation. Published by Elsevier Inc. 2022
Materias:	Spotlight on Special Topics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972615/ http://dx.doi.org/10.1016/S0735-1097(22)03135-7

Ejemplares similares

OSBORNE WAVE IN ECG AS A PREDICTOR OF HOSPITAL MORTALITY IN COVID-19 ASSOCIATED PNEUMONIA
por: Zagidullin, Naufal, et al.
Publicado: (2021)

SERUM BIOMARKERS HS-TNI AND SST-2 PREDICT LONG-TERM RISK FOR CARDIOVASCULAR EVENTS IN DISCHARGED HOSPITALIZED COVID-19 SURVIVORS
por: Zagidullin, Naufal, et al.
Publicado: (2023)

Cardiovascular Biomarkers for Prediction of in-hospital and 1-Year Post-discharge Mortality in Patients With COVID-19 Pneumonia
por: Motloch, Lukas J., et al.
Publicado: (2022)

Investigation of hs-TnI and sST-2 as Potential Predictors of Long-Term Cardiovascular Risk in Patients with Survived Hospitalization for COVID-19 Pneumonia
por: Fiedler, Lukas, et al.
Publicado: (2022)

HIGH-SENSITIVITY CARDIAC TROPONIN T FOR THE DETECTION OF MYOCARDIAL INJURY AND RISK STRATIFICATION IN COVID-19
por: De Michieli, Laura, et al.
Publicado: (2021)

UTILITY OF AN AUTOMATED ARTIFICIAL INTELLIGENCE ECHOCARDIOGRAPHY SOFTWARE IN RISK STRATIFICATION OF HOSPITALIZED COVID-19 PATIENTS
por: Wang, Tom Kai Ming, et al.
Publicado: (2021)

Early antithrombotic post-discharge therapy using prophylactic DOAC or dipyridamole improves long-term survival and cardiovascular outcomes in hospitalized COVID-19 survivors
por: Motloch, Lukas J., et al.
Publicado: (2022)

WHOSE DOSE IS IT ANYWAY? INDIVIDUAL PATIENT DOSE-RESPONSE CURVES FROM THE REMOTE-CARE PERSONAL-COVIDBP TRIAL
por: Taylor, Mike, et al.
Publicado: (2022)

IS ADENOSINE SAFE IN HOSPITALIZED PATIENTS WITH COVID-19 PNEUMONIA AND SUPRAVENTRICULAR TACHYCARDIA?
por: Zivan, Tal, et al.
Publicado: (2022)

TREATMENT OF MECHANICAL COMPLICATIONS OF ACUTE MYOCARDIAL INFARCTION DURING THE COVID-19 ERA: A COMPARISON WITH THE PRE-COVID-19 PERIOD
por: Spadaccio, Cristiano, et al.
Publicado: (2022)

IS FOCUSED CARDIAC ULTRASOUND SUFFICIENT FOR CLINICAL DECISION MAKING IN COVID-19 PANDEMIC?
por: Shkolnik, Evgeny, et al.
Publicado: (2022)

CARDIAC INJURY DESCRIBED BY CONTRAST-ENHANCED CARDIAC MAGNETIC RESONANCE IMAGING IN PATIENTS RECOVERED FROM COVID-19
por: Khokhlov, Leonid, et al.
Publicado: (2022)

J-waves in acute COVID-19: A novel disease characteristic and predictor of mortality?
por: Zagidullin, Naufal Shamilevich, et al.
Publicado: (2021)

A NOVEL APPROACH TO TEACHING CORONARY ANGIOGRAPHY USING 3D-PRINTING
por: Sabbak, Nabil, et al.
Publicado: (2022)

OUTPATIENT CARDIAC MONITORING TO DETERMINE ARRHYTHMIC BURDEN AFTER COVID-19 HOSPITALIZATION
por: Beccarino, Nicholas, et al.
Publicado: (2022)

STRAIN IMAGING AS AN EARLY PROGNOSTIC INDICATOR FOR LATE COMPLICATIONS IN COVID-19 PATIENTS
por: Devera, Justin, et al.
Publicado: (2022)

RELATIONSHIP BETWEEN PARAMETERS OF RIGHT VENTRICULAR HEMODYNAMICS TO OUTCOMES IN COVID-19: CLINICAL AND ECHOCARDIOGRAPHIC COMPARISONS BETWEEN THE FIRST AND SECOND WAVES OF THE PANDEMIC
por: Hernandez, Nolberto, et al.
Publicado: (2022)

ANALYSIS OF MYOCARDIAL INFARCTION AND MYOCARDIAL INFARCTION COMPLICATIONS BEFORE AND DURING COVID-19 PANDEMIC FROM MULTIPLE HOSPITALS
por: To, Magnus, et al.
Publicado: (2022)

COVID-19 TELEHEALTH PREPAREDNESS: A CROSS-SECTIONAL ASSESSMENT OF CARDIOLOGY PRACTICES IN THE UNITED STATES
por: Waldman, Carly, et al.
Publicado: (2022)

CORONARY MICROVASCULAR HEALTH IN PATIENTS WITH PRIOR COVID-19 INFECTION: IMPLICATIONS FOR LONG-COVID SYNDROME
por: Ahmed, Ahmed Ibrahim, et al.
Publicado: (2022)

RELATION OF 10-YEAR ASCVD RISK SCORE WITH SEVERE COVID-19 OUTCOMES
por: Arif, Yousif, et al.
Publicado: (2022)

CLUSTERING OF CLINICAL-ECHOCARDIOGRAPHIC PHENOTYPES OF COVID-19 DISEASE USING MACHINE-LEARNING TECHNIQUES
por: Hochstadt, Aviram, et al.
Publicado: (2022)

CARDIAC MARKERS AS EVIDENCE OF CARDIAC INJURY IN THE SETTING OF MULTI-SYSTEM INFLAMMATORY SYNDROME IN CHILDREN ASSOCIATED WITH COVID-19
por: Torres-Burgos, Ileana, et al.
Publicado: (2021)

CLINICAL CHARACTERISTICS AND OUTCOMES IN CARDIO-ONCOLOGY PATIENTS WITH COVID-19: ANALYSIS FROM THE COVID-19 AND CANCER CONSORTIUM (CCC19) DATABASE
por: Moey, Melissa YY, et al.
Publicado: (2021)

IS THERE A ROLE FOR α1-ANTITRYPSIN IN COVID-19?
por: Gurbel, Paul A., et al.
Publicado: (2021)

MYOCARDIAL INVOLVEMENT IN COVID-19 - DATA FROM 102 CLINICAL AND FORENSIC AUTOPSIES IN ST PETERSBURG DURING THE FIRST WAVE OF SARS-COV2 PANDEMICS
por: Platonov, Pyotr G., et al.
Publicado: (2021)

OUTCOMES OF COVID-19 IN PATIENTS WITH CARDIOVASCULAR DISEASE
por: Vu, Chau N., et al.
Publicado: (2021)

PREVALENCE OF CARDIAC INVOLVEMENT IN HOSPITALIZED PATIENTS WITH COVID-19: ECHOCARDIOGRAPHIC FINDINGS IN A REGISTRY OF 768 PATIENTS
por: Pournazari, Payam, et al.
Publicado: (2021)

AI ENHANCED ECG ENABLED RAPID NON-INVASIVE EXCLUSION OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) INFECTION
por: Attia, Zachi Itzhak, et al.
Publicado: (2021)

CHARACTERICS OF HISPANIC, NON HISPANIC WHITE AND NON-HISPANIC BLACK PATIENTS SCREENED AND HOSPITALIZED FOR COVID-19 IN CHICAGO, USA
por: Fugar, Setri, et al.
Publicado: (2021)

ECHOCARDIOGRAPHY DERIVED PREDICTORS OF WORSE OUTCOMES IN THE ACUTE PHASE OF COVID-19 PATIENTS COMPARED TO MATCHED CONTROLS
por: Omar, Alaa, et al.
Publicado: (2021)

ELEVATION OF NT-PROBNP LEVEL IS ASSOCIATED WITH HIGHER IN-HOSPITAL MORTALITY FOR COVID-19 IN ETHNIC MINORITY COMMUNITY
por: Jadhav, Preeti, et al.
Publicado: (2021)

AGE-BASED RISK FACTORS FOR SYMPTOMATIC COVID-19 IN THE MINORITY POPULATION
por: Gurbel, Paul A., et al.
Publicado: (2021)

PREDICTORS OF COVID-19 RELATED INTRA-CARDIAC THROMBUS FROM ADMISSION LABORATORY VALUES
por: Rastogi, Sheena, et al.
Publicado: (2021)

TELE-PHARMACY CARE OF GUIDELINE-DIRECTED MEDICAL THERAPY IN HEART FAILURE PATIENTS IS FEASIBLE DURING THE COVID-19 PANDEMIC
por: Randhawa, Varinder, et al.
Publicado: (2021)

CARDIAC ARREST AND CLINICAL OUTCOMES IN COVID 19 PATIENTS : A SINGLE CENTER EXPERIENCE
por: Mechineni, Ashesha, et al.
Publicado: (2021)

STATIN USE AND OUTCOMES IN HOSPITALIZED PATIENTS WITH SARS-COV-2 INFECTION
por: Siddiqi, Hasan, et al.
Publicado: (2021)

TROPONIN-I PREDICTS MAJOR ADVERSE CARDIOVASCULAR EVENTS AND RISK OF MORTALITY IN COVID-19 PATIENTS
por: Patel, Chirag, et al.
Publicado: (2021)

USE OF SIMULATION FOR ADVANCED RESUSCITATION OF IN-HOSPITAL CARDIAC ARREST PATIENTS WITH SUSPECTED OR CONFIRMED COVID-19
por: Proulx, Laurie-Anne Boivin, et al.
Publicado: (2021)

ASSOCIATION OF MCCONNELL’S SIGN WITH MORTALITY AMONG PATIENTS HOSPITALIZED WITH COVID-19
por: Yeo, Ilhwan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_83prmohh48nfe6lg04i35p18kd